Search

Your search keyword '"Camuzat A"' showing total 909 results

Search Constraints

Start Over You searched for: Author "Camuzat A" Remove constraint Author: "Camuzat A"
909 results on '"Camuzat A"'

Search Results

1. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes

2. Integrative genetic analysis illuminates ALS heritability and identifies risk genes

3. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes

4. Homozygous GRN mutations: unexpected phenotypes and new insights into pathological and molecular mechanisms

5. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

6. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

7. Integrative genetic analysis illuminates ALS heritability and identifies risk genes

8. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

9. MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis

10. C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice

11. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

12. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

13. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

14. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

16. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

17. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

18. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

19. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

20. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

21. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

22. Differential early subcortical involvement in genetic FTD within the GENFI cohort

23. Disease Progression Score Estimation From Multimodal Imaging and MicroRNA Data Using Supervised Variational Autoencoders

24. Early neurotransmitters changes in prodromal frontotemporal dementia

25. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

26. Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias

27. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

28. Temporal order of clinical and biomarker changes in familial frontotemporal dementia

30. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort

31. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

32. Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

33. C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice

34. Integrative genetic analysis illuminates ALS heritability and identifies risk genes

35. Integrative genetic analysis illuminates ALS heritability and identifies risk genes

36. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

37. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

38. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

39. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

40. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

42. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

44. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

45. Primary progressive aphasias associated with C9orf72 expansions: Another side of the story

46. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia

48. A unique common ancestor introduced P301L mutation in MAPT gene in frontotemporal dementia patients from Barcelona (Baix Llobregat, Spain)

49. New Antibody-Free Mass Spectrometry-Based Quantification Reveals That C9ORF72 Long Protein Isoform Is Reduced in the Frontal Cortex of Hexanucleotide-Repeat Expansion Carriers

50. France A Chronicle of French Family Law: 2020

Catalog

Books, media, physical & digital resources